Market Cap 4.28M
Revenue (ttm) 0.00
Net Income (ttm) -13.19M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,907,500
Avg Vol 5,820,207
Day's Range N/A - N/A
Shares Out 10.93M
Stochastic %K 55%
Beta 1.90
Analysts Strong Buy
Price Target $30.00

Company Profile

Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatment for hepatocellular carcinoma (HCC), metabolic liver diseases, and chronic liver diseases in the United States. It developed Rencofilstat, a therapeutic drug candidate that binds and inhibits the function of a specific class of isomerase enzymes called cyclophilins that regulates protein folding, as well as preclinical experiments of Rencofilstat reflects decreased liver fibrosis; liver inflammation...

Industry: Biotechnology
Sector: Healthcare
Phone: 732 902 4000
Address:
55 Madison Avenue, Suite 400 PMB No. 4362, Morristown, United States
vu_jade
vu_jade Aug. 14 at 8:39 AM
$HEPA Smells like WABISTICS
0 · Reply
_unavailable_
_unavailable_ Aug. 13 at 12:47 PM
$HEPA The new 10Q is out! "We had no revenues during the six months ended June 30, 2026 and 2025, because we have not commercialized any of our medical diagnostic products and we do not expect to have such products for several years, if at all."
1 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Aug. 13 at 3:45 AM
$HEPA CEO purchased 2,000,000 shares at $0.05 for a total of $100,000. Stetz Gary S. now owns 3,250,000 shares. https://ceo-buys.com
0 · Reply
AlertsAndNews
AlertsAndNews Aug. 13 at 2:50 AM
$HEPA OTC stock now... insiders are busy. Vincent S. LoPriore (Executive Chairman) Buys 20M Shares @ $0.03 | Michael J. Purcell (Director) Buys 4M Shares @ $0.03 | Gary S. Stetz II (Director) Buys 1M Shares @ $0.03 (Form 4)
0 · Reply
norenar07
norenar07 Aug. 8 at 6:20 AM
$HEPA This people have been destroying shareholders portfolios and taking their money for many many years. They have changed their names many times. They have reverse split so many times, that they can’t do it anymore. They should’ve been investigated a long time ago.
0 · Reply
aiolus
aiolus Aug. 8 at 1:57 AM
$HEPA HEPA shareholders may want to take a closer look at the May 2025 sale of Rencofilstat to Panetta Partners. Rencofilstat had been Hepion’s lead drug asset, yet the company transferred the patents, know-how, clinical-trial data and drug product for nominal upfront consideration. Shareholders received CVRs with maximum aggregate milestone payments of $4.5 million if the drug eventually achieves FDA approval and major sales milestones. Panetta is associated with Gabriele Cerrone, who has been described as a co-founder of Hepion. I am not alleging wrongdoing, but I think shareholders should ask whether there was an independent valuation, market check, competing bids or a fairness review. It would also be useful to know how the Board evaluated any potential conflicts of interest. A Delaware Section 220 books-and-records request could potentially provide answers. Are any U.S. HEPA shareholders or attorneys looking into this transaction?
2 · Reply
Moneybucks
Moneybucks Aug. 7 at 8:57 PM
$HEPA https://www.sec.gov/Archives/edgar/data/1583771/000214683826000001/xslSCHEDULE_13D_X02/primary_doc.xml
0 · Reply
Pharm_Hand
Pharm_Hand Aug. 4 at 7:33 PM
$TGTX @Chartist0_0 , you're needed over at $HEPA
0 · Reply
Moneybucks
Moneybucks Aug. 4 at 3:21 AM
$HEPA Gamestop come kitty kitty
0 · Reply
Moneybucks
Moneybucks Aug. 4 at 3:20 AM
$HEPA The balls on this bull are swinging big untouched Gem of the stock market why do you think they kept so much secret im invested with a few bucks
0 · Reply
Latest News on HEPA
No data available.
vu_jade
vu_jade Aug. 14 at 8:39 AM
$HEPA Smells like WABISTICS
0 · Reply
_unavailable_
_unavailable_ Aug. 13 at 12:47 PM
$HEPA The new 10Q is out! "We had no revenues during the six months ended June 30, 2026 and 2025, because we have not commercialized any of our medical diagnostic products and we do not expect to have such products for several years, if at all."
1 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Aug. 13 at 3:45 AM
$HEPA CEO purchased 2,000,000 shares at $0.05 for a total of $100,000. Stetz Gary S. now owns 3,250,000 shares. https://ceo-buys.com
0 · Reply
AlertsAndNews
AlertsAndNews Aug. 13 at 2:50 AM
$HEPA OTC stock now... insiders are busy. Vincent S. LoPriore (Executive Chairman) Buys 20M Shares @ $0.03 | Michael J. Purcell (Director) Buys 4M Shares @ $0.03 | Gary S. Stetz II (Director) Buys 1M Shares @ $0.03 (Form 4)
0 · Reply
norenar07
norenar07 Aug. 8 at 6:20 AM
$HEPA This people have been destroying shareholders portfolios and taking their money for many many years. They have changed their names many times. They have reverse split so many times, that they can’t do it anymore. They should’ve been investigated a long time ago.
0 · Reply
aiolus
aiolus Aug. 8 at 1:57 AM
$HEPA HEPA shareholders may want to take a closer look at the May 2025 sale of Rencofilstat to Panetta Partners. Rencofilstat had been Hepion’s lead drug asset, yet the company transferred the patents, know-how, clinical-trial data and drug product for nominal upfront consideration. Shareholders received CVRs with maximum aggregate milestone payments of $4.5 million if the drug eventually achieves FDA approval and major sales milestones. Panetta is associated with Gabriele Cerrone, who has been described as a co-founder of Hepion. I am not alleging wrongdoing, but I think shareholders should ask whether there was an independent valuation, market check, competing bids or a fairness review. It would also be useful to know how the Board evaluated any potential conflicts of interest. A Delaware Section 220 books-and-records request could potentially provide answers. Are any U.S. HEPA shareholders or attorneys looking into this transaction?
2 · Reply
Moneybucks
Moneybucks Aug. 7 at 8:57 PM
$HEPA https://www.sec.gov/Archives/edgar/data/1583771/000214683826000001/xslSCHEDULE_13D_X02/primary_doc.xml
0 · Reply
Pharm_Hand
Pharm_Hand Aug. 4 at 7:33 PM
$TGTX @Chartist0_0 , you're needed over at $HEPA
0 · Reply
Moneybucks
Moneybucks Aug. 4 at 3:21 AM
$HEPA Gamestop come kitty kitty
0 · Reply
Moneybucks
Moneybucks Aug. 4 at 3:20 AM
$HEPA The balls on this bull are swinging big untouched Gem of the stock market why do you think they kept so much secret im invested with a few bucks
0 · Reply
Moneybucks
Moneybucks Aug. 4 at 2:18 AM
$HEPA Lets turn this into a horse race😂
0 · Reply
Moneybucks
Moneybucks Aug. 4 at 1:58 AM
$HEPA Let the games begin😂
0 · Reply
SmartestMoney
SmartestMoney Jul. 21 at 3:05 PM
1 · Reply
Moneybucks
Moneybucks Jul. 14 at 3:54 PM
$HEPA Why would the BOD approve the sale of Rencofilstat before releasing the data to shareholders? The CVR'S are worthless Brancaccio just gave it away to Panetta partners where Brancaccio's buddy Gabriel Cerrone is at. How many companies have Brancaccio and Cerrone been involved with together and that who the BOD approves to give away Rencofilstat to. Their is no way all of this could be legal what a bunch of thieves.
2 · Reply
Moneybucks
Moneybucks Jul. 13 at 9:52 PM
$HEPA Maybe someone should come in and buy 500k shares😂 how could their be shares for sale if there really is only like 11.6 million in the float would be a good one for SEC and Finra to watch
1 · Reply
Moneybucks
Moneybucks Jul. 13 at 9:49 PM
$HEPA Big question is why is Hepion paying to file patents for Rencofilstat? The applicant on a patent filing is who pays the fees.
0 · Reply
Moneybucks
Moneybucks Jul. 7 at 10:49 PM
1 · Reply
Moneybucks
Moneybucks Jul. 2 at 11:42 PM
$HEPA https://www.sec.gov/ix?doc=/Archives/edgar/data/0001583771/000149315226031918/form8-k.htm
2 · Reply
BitterTwit2
BitterTwit2 Jul. 1 at 1:25 PM
$HEPA This stock gives me sneaky vibes... Wouldn't be surprised to check in one day to see some mind blowing news...
1 · Reply
Moneybucks
Moneybucks Jun. 27 at 4:51 AM
$HEPA 20 day MA closing in on 50 day MA on weekly we are close to a news release
1 · Reply
Gimmeyamoney
Gimmeyamoney Jun. 23 at 8:59 PM
$HEPA haven't looked at this since it dropped down to nothing taking a painful amount of money with it. After the mourning period... Someone is able to give a short response on if this company is still doing something? Did we figure out where renco ended up and something still being done with it ? Any odds of hepa ever reviving (with renco?)?
2 · Reply
Moneybucks
Moneybucks Jun. 18 at 12:23 PM
$HEPA Any guesses what the plan will be for the 8 million shares that were approved?
2 · Reply